Another trial found a significantly positive relationship between HER2 expression and increased platelets through vascular endothelial growth factor (VEGF)29, but whether thrombocytopenia was caused by decreased HER2-positive breast cancer cells still remained unknown. The gene discussed is VEGFA; the disease is breast carcinoma.